{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T05:05:45Z","timestamp":1726290345906},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012574","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T08:43:45Z","timestamp":1538210625000},"page":"e12574","source":"Crossref","is-referenced-by-count":6,"title":["Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease"],"prefix":"10.1097","volume":"97","author":[{"given":"Hyun","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geunjoo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-86-20210309","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5056\/jnm.2014.20.1.6","article-title":"New and future drug development for gastroesophageal reflux disease","volume":"20","author":"Maradey-Romero","year":"2014","journal-title":"J Neurogastroenterol Motil"},{"key":"R2-86-20210309","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"R3-86-20210309","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"R4-86-20210309","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gutjnl-2016-311715","article-title":"Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus","volume":"65","author":"Fock","year":"2016","journal-title":"Gut"},{"key":"R5-86-20210309","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.3748\/wjg.v19.i39.6523","article-title":"Gastroesophageal reflux disease: update on inflammation and symptom perception","volume":"19","author":"Altomare","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R6-86-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2014where next","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-86-20210309","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cgh.2011.07.008","article-title":"Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease","volume":"10","author":"Hungin","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-86-20210309","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"R9-86-20210309","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-86-20210309","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015","volume":"51","author":"Iwakiri","year":"2016","journal-title":"J Gastroenterol"},{"key":"R11-86-20210309","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s10620-017-4866-6","article-title":"Vonoprazan: a novel and potent alternative in the treatment of acid-related diseases","volume":"63","author":"Yang","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R12-86-20210309","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","article-title":"Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors","volume":"61","author":"Sifrim","year":"2012","journal-title":"Gut"},{"key":"R13-86-20210309","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R14-86-20210309","doi-asserted-by":"crossref","first-page":"1756283X17745776","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.","volume":"11","author":"Sugano","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"key":"R15-86-20210309","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1756283X17705329","article-title":"A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis","volume":"10","author":"Iwakiri","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"R16-86-20210309","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.kjms.2017.07.004","article-title":"Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease","volume":"33","author":"Shinozaki","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"R17-86-20210309","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/ctg.2015.39","article-title":"Potassium-competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease","volume":"6","author":"Hunt","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"R18-86-20210309","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","article-title":"Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study","volume":"65","author":"Murakami","year":"2016","journal-title":"Gut"},{"key":"R19-86-20210309","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-86-20210309","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3748\/wjg.v24.i14.1550","article-title":"Maintenance for healed erosive esophagitis: phase III comparison of vonoprazan with lansoprazole","volume":"24","author":"Ashida","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R21-86-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2016.12.001","article-title":"Evaluation of the efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a phase iii, randomized, double-blind, placebo-controlled, multicenter study","volume":"81-82","author":"Kinoshita","year":"2016","journal-title":"Curr Ther Res Clin Exp"},{"key":"R22-86-20210309","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R24-86-20210309","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R25-86-20210309","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R26-86-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R27-86-20210309","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jebm.12002","article-title":"Reporting number needed to treat\u2019 in meta-analyses: a cross-sectional study","volume":"5","author":"Naing","year":"2012","journal-title":"J Evid Based Med"},{"key":"R28-86-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Bias in location and selection of studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"R29-86-20210309","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R30-86-20210309","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"R31-86-20210309","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"R32-86-20210309","doi-asserted-by":"crossref","first-page":"e000197","DOI":"10.1136\/bmjgast-2017-000197","article-title":"Study for every other day administration of vonoprazan in maintenance treatment of erosive GERD: study protocol for a multicentre randomised cross-over study","volume":"5","author":"Kato","year":"2018","journal-title":"BMJ Open Gastroenterol"},{"key":"R33-86-20210309","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000456072","article-title":"Efficacy of vonoprazan for proton pump inhibitor-resistant reflux esophagitis","volume":"95","author":"Hoshino","year":"2017","journal-title":"Digestion"},{"key":"R34-86-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000475658","article-title":"Factors associated with potassium-competitive acid blocker non-response in patients with proton pump inhibitor-refractory gastroesophageal reflux disease","volume":"95","author":"Okuyama","year":"2017","journal-title":"Digestion"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000012574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:31:42Z","timestamp":1620963102000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809280-00086"}},"subtitle":["A protocol for a systematic review with meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012574","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}